Target intelligence / Profile preview

Mitochondrial thiol-containing proteins

Molecular classification
Enzyme, Antioxidant, Redox-regulating protein, Other
01

Overview

Mitochondrial thiol-containing proteins are a functional class of proteins located within the mitochondria that utilize the redox-active properties of cysteine thiol (-SH) groups for catalysis, structural stability, and signaling (PMID: 22503544). This group encompasses key antioxidant enzymes such as thioredoxin 2 (Trx2), thioredoxin reductase 2 (TrxR2), and peroxiredoxins (Prx3, Prx5), which are vital for neutralizing superoxide and hydrogen peroxide generated during oxidative phosphorylation (PMID: 15822172). Beyond antioxidant defense, these thiols are found in metabolic enzymes like alpha-ketoglutarate dehydrogenase and components of the electron transport chain, where they act as sensors for the mitochondrial redox state (PMID: 28847445). In pathological states such as cancer, mitochondrial thiols are often overexpressed to provide a survival advantage against elevated oxidative stress, whereas in neurodegenerative diseases, their oxidative modification contributes to mitochondrial dysfunction and cell death (PMID: 23603808). Therapeutic strategies often involve the use of electrophilic compounds or metal complexes, such as auranofin, which covalently inhibit these proteins to induce mitochondrial-mediated apoptosis in malignant cells (PMID: 29413440). However, the therapeutic window is often narrow due to the ubiquitous nature of thiol groups in the cytosol and other organelles, necessitating the development of mitochondria-targeted delivery systems (PMID: 25130392).

Other names
Mitochondrial protein thiolsMitochondrial redox-sensitive proteinsMitochondrial thiol proteome
02

Mechanism of action

Covalent modification of cysteine thiol groups, inhibition of mitochondrial thioredoxin reductase (TrxR2), and induction of mitochondrial oxidative stress leading to the opening of the mitochondrial permeability transition pore (mPTP) and subsequent apoptosis (PMID: 29413440, PMID: 22503544).

03

Biological functions

Redox homeostasisApoptosisMetabolismOxidative stress responseSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammation
05

Safety considerations

Systemic oxidative stressHepatotoxicityNephrotoxicityLack of specificity for mitochondrial vs. cytosolic thiols
06

Interacting drugs

Auranofin

5 more in the full profile.

07

Biomarkers

Mitochondrial ROS levelsGSH/GSSG ratioThioredoxin reductase activityProtein thiol oxidation state

Beyond the preview

Go deeper on Mitochondrial thiol-containing proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial thiol-containing proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call